Allergan has announced its decision to shut down by the end of this year the R&D facilities of its French subsidiary, which moved to a new high-tech site in 2002. The measure, which will lead to the layoff of 126 of the company's 195 employees on the premises, has been ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.